Delivery Order SPE2DB22D1202-SPE2DB24FVAH8

Award Date 5/14/24
Potential Completion Date 5/15/24
Potential Value $1.8K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. government's Defense Logistics Agency (DLA) awarded a delivery order contract worth $5,753.28 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of CORTIFOAM 10% AEROSOL 15GM, a pharmaceutical product, with an ultimate completion date of October 25, 2023. This contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,195.72 firm fixed-price delivery order is for the supply of CORTIFOAM 10% AEROSOL 15GM, a medical product. The contract has an ultimate completion date of May 24, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA...
This federal contract award, valued at $1,136.83, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CORTIFOAM 10% AEROSOL 15GM, a medical product, and has a completion date of May 5, 2023. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation indicated. Amerisourcebergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of medical supplies, specifically "CORTIFOAM 10% AEROSOL 15GM", with a ceiling value of $10,775.58 and a completion date of December 27, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 and running...
This federal contract award, with the ID SPE2DB22D2007|SPE2DB24FH6TP, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CORTIFOAM 10% AEROSOL 15GM, a medical product, with a ceiling value of $9,390.13 and a completion date of November 1, 2023. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The delivery order, valued at $3,296.24, is for the supply of CORTIFOAM 10% AEROSOL 15GM, a medical product. The IDC, valued at $999,999,999 and running through November 2026, serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and...
This contract award is for the delivery of CORTIFOAM 10% AEROSOL 15GM medical supplies to the Defense Logistics Agency (DLA). The contract, valued at $3,117.12, is a Firm Fixed Price Delivery Order with an ultimate completion date of March 22, 2023. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
This federal contract award, with ID SPE2DB22D1017|SPE2DB25FF4NL, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,562.92 firm fixed-price delivery order is for the supply of CORTIFOAM 10% AEROSOL 15GM, a medical product, with a performance period through February 3, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award, SPE2DX15D3012|SPE2DX24F8ET3, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of CORTIFOAM 10% AEROSOL 15GM, a medical supply, with a ceiling value of $6,700.65 and a period of performance through December 1, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal...
This federal contract award is for the delivery of PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,050.27 delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a firm fixed price and an ultimate completion date of May 18, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FVAH8
    Delivery Order

This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA). The contract is for the supply of 4564603968 - CORTIFOAM 10% AEROSOL 15GM, a pharmaceutical product. The contract has a ceiling value of $1,845.39 and an ultimate completion date of May 15, 2024.

Amerisourcebergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for the company to deliver a range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

This contract award does not have a set-aside designation, indicating it was awarded on a full and open competition basis. Amerisourcebergen Drug Corp, as the prime contractor, leverages its parent company's extensive pharmaceutical distribution capabilities to fulfill government contracts, supporting the DLA's mission to provide critical medical commodities to the U.S. Armed Forces and other government agencies.

Generated 8/13/24, 11:02 AM